Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: The Global Rheumatic Heart Disease Registry (the REMEDY study)

European Heart Journal

Volumn 36, Issue 18, 2015, Pages 1115-1122

  Zühlke, Liesl ^a,b   Engel, Mark E ^a   Karthikeyan, Ganesan ^c   Rangarajan, Sumathy ^d   Mackie, Pam ^d   Cupido, Blanche ^a   Mauff, Katya ^b   Islam, Shofiqul ^d   Joachim, Alexia ^a   Daniels, Rezeen ^a   Francis, Veronica ^a   Ogendo, Stephen ^e   Gitura, Bernard ^f   Mondo, Charles ^g   Okello, Emmy ^h   Lwabi, Peter ^h   Al Kebsi, Mohammed M ⁱ   Hugo Hamman, Christopher ^b,j   Sheta, Sahar S ^k   Haileamlak, Abraham ^l   Daniel, Wandimu ^l   Goshu, Dejuma Y ^m   Abdissa, Senbeta G ^m   Desta, Araya G ^m   Shasho, Bekele A ^m   Begna, Dufera M ^m   Elsayed, Ahmed ⁿ   Ibrahim, Ahmed S ⁿ   Musuku, John ^o   Bode Thomas, Fidelia ^p   Okeahialam, Basil N ^p   Ige, Olukemi ^p   Sutton, Christopher ^q   Misra, Rajeev ^q   Abul Fadl, Azza ^r   Kennedy, Neil ^s   Damasceno, Albertino ^t   Sani, Mahmoud ^u   Ogah, Okechukwu S ^v,w,x   Olunuga, Taiwo ^x   Elhassan, Huda H M ^y   Mocumbi, Ana Olga ^t   Adeoye, Abiodun M ^v   Mntla, Phindile ^q   Ojji, Dike ^z   Mucumbitsi, Joseph ^aa   Teo, Koon ^d   Yusuf, Salim ^d   Mayosi, Bongani M ^a   more..

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^d MCMASTER UNIVERSITY   (Canada)

^e UNIVERSITY OF NAIROBI   (Kenya)

^f Kenyatta National Teaching and Referral Hospital   (Kenya)

^g MULAGO HOSPITAL   (Uganda)

^h UGANDA HEART INSTITUTE   (Uganda)

ⁱ SANA A UNIVERSITY   (Yemen)

^j Windhoek Central Hospital   (Namibia)

^k CAIRO UNIVERSITY   (Egypt)

^l JIMMA UNIVERSITY   (Ethiopia)

^m ADDIS ABABA UNIVERSITY   (Ethiopia)

ⁿ ALZAIEM ALAZHARI UNIVERSITY   (Sudan)

^o UNIVERSITY TEACHING HOSPITAL   (Zambia)

^p UNIVERSITY OF JOS   (Nigeria)

^q UNIVERSITY OF LIMPOPO   (South Africa)

^r BENHA UNIVERSITY   (Egypt)

^s UNIVERSITY OF MALAWI   (Malawi)

^t EDUARDO MONDLANE UNIVERSITY   (Mozambique)

^u BAYERO UNIVERSITY   (Nigeria)

^v UNIVERSITY OF IBADAN   (Nigeria)

^w Nigeria Ministry of Health   (Nigeria)

^x FEDERAL MEDICAL CENTER   (Nigeria)

^y Ahmed Gasim Teaching Hospital   (Sudan)

^z UNIVERSITY OF ABUJA   (Nigeria)

^aa KING FAISAL HOSPITAL   (Rwanda)

more..

Author keywords

Atrial fibrillation; Congestive heart failure; Infective endocarditis; Rheumatic heart disease; Stroke; Valve surgery; Valvuloplasty

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIURETIC AGENT; PENICILLIN DERIVATIVE; WARFARIN; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ANTIBIOTIC PROPHYLAXIS; AORTA STENOSIS; AORTA VALVE DISEASE; ARTICLE; ATRIAL FIBRILLATION; BACTERIAL ENDOCARDITIS; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; CONTRACEPTION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE DISEASE; MITRAL VALVE REGURGITATION; MITRAL VALVE STENOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; PULMONARY VALVE STENOSIS; REGISTER; RHEUMATIC HEART DISEASE; SINUS RHYTHM; SOCIAL STATUS; TRICUSPID VALVE STENOSIS; VALVULAR HEART DISEASE; VALVULOPLASTY; AGE DISTRIBUTION; CLINICAL TRIAL; COMPLICATION; CROSS-SECTIONAL STUDY; DEVELOPING COUNTRY; EVIDENCE BASED MEDICINE; HEALTH; HEART VALVE DISEASES; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PILOT STUDY; SEX RATIO;

ADMINISTRATION, ORAL; ADULT; AGE DISTRIBUTION; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; ANTICOAGULANTS; CROSS-SECTIONAL STUDIES; DEVELOPING COUNTRIES; EVIDENCE-BASED MEDICINE; FEMALE; GLOBAL HEALTH; HEART VALVE DISEASES; HUMANS; MALE; PENICILLINS; PILOT PROJECTS; PROSPECTIVE STUDIES; RHEUMATIC HEART DISEASE; SEX DISTRIBUTION;

EID: 84929617058     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehu449     Document Type: Article

References (36)

1. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group a streptococcal diseases. Lancet Infect Dis 2005;5:685-694.
2. Paar JA, Berrios NM, Rose JD, Cáceres M, Penã R, PérezW, Chen-Mok M, Jolles E, Dale JB. Prevalence of rheumatic heart disease in children and young adults in Nicaragua. Am J Cardiol 2010;105:1809-1814.
3. Diao M, Kane A, Ndiaye MB, Mbaye A, Bodian M, Dia MM, Sarr M, Kane A, Monsuez J-J, Ba SA. Pregnancy in women with heart disease in Sub-Saharan Africa. Arch Cardiovasc Dis. 2011;104:370-374.
4. Koegelenberg CF, Doubell AF, Orth H, Reuter H. Infective endocarditis in the western cape province of south Africa: A three-year prospective study. QJM 2003; 96:217-225.
5. Benjamin EJ,Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillationonthe risk of death: The Framingham heart study. Circulation 1998;98: 946-952.
6. Carapetis JR. Rheumatic heart disease in Asia. Circulation 2008;118:2748-2753.
7. Remenyi B, Carapetis J, Wyber R, Taubert K, Mayosi BM. Position statement of the world heart federation on the prevention and control of rheumatic heart disease. Nat Rev Cardiol 2013;10:284-292.
8. Carapetis JR, Mayosi BM, Kaplan EL. Controlling rheumatic heart disease in developing countries. Cardiovasc J S Afr 2006;17:164-165.
9. Lawrence JG, Carapetis JR, Griffiths K, Edwards K, CondonJR. Acute rheumatic fever and rheumatic heart disease: incidence and progression in the northern territory of Australia, 1997 to 2010. Circulation 2013;128:492-501.
10. Manyemba J, Mayosi BM. Intramuscular penicillin is more effective than oral penicillin in secondary prevention of rheumatic fever-A systematic review. S Afr Med J 2003; 93:212-218.
11. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP III, Guyton RA, O'Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM III, Thomas JD. 2014 AHA/ ACCguideline for the management of patients with valvular heart disease: executive summary: A report of the American college of cardiology/American Heart Association Task Force on practice guidelines. Circulation 2014;129:2440-2492.
12. RHDAustralia (ARF/RHD writing group). Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease. Darwin, Australia: RHDAustralia, Menzies School of Health Research; 2012.
13. Bassili A, Zaher SR, Zaki A, Abdel-Fattah M, Tognoni G. Profile of secondary prophylaxis among children with rheumatic heart disease in Alexandria, Egypt. East Mediterr Health J 2000;6:437-446.
14. Pelajo CF, Lopez-Benitez JM, Torres JM, de Oliveira SK. Adherence to secondary prophylaxis and disease recurrence in 536 brazilian children with rheumatic fever. Pediatr Rheumatol Online J 2010;8:22.
15. Oldgren J, Healey JS, Ezekowitz M, Commerford P, Avezum A, Pais P, Zhu J, Jansky P, Sigamani A, Morillo CA, Liu L, Damasceno A, Grinvalds A, Nakamya J, Reilly PA, Keltai K, Van Gelder IC, Yusufali AH, Watanabe E, Wallentin L, Connolly SJ, Yusuf S. Variations in cause and management of atrial fibrillation in a prospective registry of 15 400 emergency department patients in 46 countries: The RE-LY atrial fibrillation registry. Circulation 2014;129:1568-1576.
16. Zuhlke L, Mirabel M, Marijon E. Congenital heart disease and rheumatic heart disease in Africa: recent advances and current priorities. Heart 2013;99:1554-1561.
17. KarthikeyanG, Zuhlke L, Engel M, Rangarajan S, Yusuf S, TeoK, Mayosi BM. Rationale and design of a global rheumatic heart disease registry: The remedy study. Am Heart J 2012;163:535-540.
18. Webb R, Wilson NJ, Lennon D, Marijon E, Celermajer DS, Jouven X. Rheumatic heart disease detected by echocardiographic screening. N Engl J Med 2007;357: 2088-2089.
19. World Health Organization. Rheumatic fever and rheumatic heart disease: report of awhoexpert consultation, Geneva, 29 October-1November 2001.WHOTechnical Report Series. 2004.
20. Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basánez M-G, Baxter A, Bell ML, Benjamin EJ, Bennett D, Bernabé E, Bhalla K, Bhandari B, Bikbov B, Abdulhak AB, Birbeck G, Black JA, Blencowe H, Blore JD, Blyth F, Bolliger I, Bonaventure A, Boufous S, Bourne R, Boussinesq M, Braithwaite T, Brayne C, Bridgett L, Brooker S, Brooks P, Brugha TS, Bryan-Hancock C, Bucello C, Buchbinder R, Buckle G, Budke CM, Burch M, Burney P, Burstein R, Calabria B, Campbell B, Canter CE, Carabin H, Carapetis J, Carmona L, Cella C, Charlson F, Chen H, Cheng AT-A, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahiya M, Dahodwala N, Damsere-Derry J, Danaei G, Davis A, Leo DD, Degenhardt L, Dellavalle R, Delossantos A, Denenberg J, Derrett S, Des Jarlais DC, Dharmaratne SD, Dherani M, Diaz-Torne C, Dolk H, Dorsey ER, Driscoll T, Duber H, Ebel B, Edmond K, Elbaz A, Ali SE, Erskine H, Erwin PJ, Espindola P, Ewoigbokhan SE, Farzadfar F, Feigin V, Felson DT, Ferrari A, Ferri CP, Fèvre EM, Finucane MM, Flaxman S, Flood L, Foreman K, Forouzanfar MH, Fowkes FGR, Fransen M, Freeman MK, Gabbe BJ, Gabriel SE, Gakidou E, Ganatra HA, Garcia B, Gaspari F, Gillum RF, Gmel G, Gonzalez-Medina D, Gosselin R, Grainger R, Grant B, Groeger J, Guillemin F, Gunnell D, Gupta R, Haagsma J, Hagan H, Halasa YA, Hall W, Haring D, Haro JM, Harrison JE, Havmoeller R, Hay RJ, Higashi H, Hill C, Hoen B, Hoffman H, Hotez PJ, Hoy D, Huang JJ, Ibeanusi SE, Jacobsen KH, James SL, Jarvis D, Jasrasaria R, Jayaraman S, Johns N, Jonas JB, Karthikeyan G, Kassebaum N, Kawakami N, Keren A, Khoo J-P, King CH, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Laden F, Lalloo R, Laslett LL, Lathlean T, Leasher JL, Lee YY, Leigh J, Levinson D, Lim SS, Limb E, Lin JK, Lipnick M, Lipshultz SE, Liu W, Loane M, Ohno SL, Lyons R, Mabweijano J, MacIntyre MF, Malekzadeh R, Mallinger L, Manivannan S, Marcenes W, March L, Margolis DJ, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGill N, McGrath J, Medina-Mora ME, Meltzer M, Mensah GA, Merriman TR, Meyer A-C, Miglioli V, Miller M, Miller TR, Mitchell PB, Mock C, Mocumbi AO, Moffitt TE, Mokdad AA, Monasta L, Montico M, Moradi-Lakeh M, Moran A, Morawska L, Mori R, Murdoch ME, Mwaniki MK, Naidoo K, Nair MN, Naldi L, Narayan KMV, Nelson PK, Nelson RG, Nevitt MC, Newton CR, Nolte S, Norman P, Norman R, O'Donnell M, O'Hanlon S, Olives C, Omer SB, Ortblad K, Osborne R, Ozgediz D, Page A, Pahari B, Pandian JD, Rivero AP, Patten SB, Pearce N, Padilla RP, Perez-Ruiz F, Perico N, Pesudovs K, Phillips D, Phillips MR, Pierce K, Pion S, Polanczyk GV, Polinder S, Pope CA, Popova S, Porrini E, Pourmalek F, Prince M, Pullan RL, Ramaiah KD, Ranganathan D, Razavi H, Regan M, Rehm JT, Rein DB, Remuzzi G, Richardson K, Rivara FP, Roberts T, Robinson C, De Leòn FR, Ronfani L, Room R, Rosenfeld LC, Rushton L, Sacco RL, Saha S, Sampson U, Sanchez-Riera L, Sanman E, Schwebel DC, Scott JG, Segui-Gomez M, Shahraz S, Shepard DS, Shin H, Shivakoti R, Singh D, Singh GM, Singh JA, Singleton J, Sleet DA, Sliwa K, Smith E, Smith JL, Stapelberg NJC, Steer A, Steiner T, Stolk WA, Stovner LJ, Sudfeld C, Syed S, Tamburlini G, Tavakkoli M, Taylor HR, Taylor JA, Taylor WJ, Thomas B, Thomson WM, Thurston GD, Tleyjeh IM, Tonelli M, Towbin JA, Truelsen T, Tsilimbaris MK, Ubeda C, Undurraga EA, van der Werf MJ, van Os J, Vavilala MS, Venketasubramanian N, Wang M, Wang W, Watt K, Weatherall DJ, Weinstock MA, Weintraub R, Weisskopf MG, Weissman MM, White RA, Whiteford H, Wiebe N, Wiersma ST, Wilkinson JD, Williams HC, Williams SRM, Witt E, Wolfe F, Woolf AD, Wulf S, Yeh P-H, Zaidi AKM, Zheng Z-J, Zonies D, Lopez AD. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the global burden of disease study 2010. The Lancet 2012;380: 2197-2223.
21. Mocumbi AO, Sliwa K. Women's cardiovascular health in Africa. Heart 2012;98: 450-455.
22. Watkins D, Sebitloane M, Engel M, Mayosi B. The burden of antenatal heart disease in South Africa: A systematic review. BMC Cardiovasc Dis 2012;12:23.
23. Thorne S, MacGregor A, Nelson-Piercy C. Risks of contraception and pregnancy in heart disease. Heart 2006;92:1520-1525.
24. Sliwa K, Carrington M, Mayosi BM, Zigiriadis E, Mvungi R, Stewart S. Incidence and characteristics of newly diagnosed rheumatic heart disease in urban African adults: insights from the heart of Soweto study. Eur Heart J 2010;31:719-727.
25. SaniMU, Karaye KM, BorodoMM. Prevalence and pattern of rheumatic heart disease in the Nigerian savannah: an echocardiographic study. Cardiovasc J Afr 2007;18: 295-299.
26. Tantchou Tchoumi JC, Butera G. Profile of cardiac disease in Cameroon and impact on health care services. Cardiovasc Diagn Ther 2013;3:236-243.
27. Demirbag R, Sade LE, Aydin M, Bozkurt A, Acarturk E. The Turkish registry of heart valve disease. Turk Kardiyoloji Dernegi Arsivi: Turk Kardiyoloji Derneginin Yayin Organidir. 2013;41:1-10.
28. Nordet P, Lopez R, Duenas A, Sarmiento L. Prevention and control of rheumatic fever and rheumatic heart disease: The Cuban experience (1986-1996-2002). Cardiovasc J Afr 2008;19:135-140.
29. Remond MG, Severin KL, Hodder Y, Martin J, Nelson C, Atkinson D, Maguire GP. Variability in disease burden and management of rheumatic fever and rheumatic heart disease in two regions of tropical Australia. Intern Med J 2013;43:386-393.
30. Lue HC, Chen CL,WeiH. Some problems in long-termprevention of streptococcal infection among children with rheumatic heart disease in Taiwan. Jpn Heart J 1976;17: 550-559.
31. Walker KG, Human DG, De MoorMM, Sprenger KJ. The problem of compliance in rheumatic fever. S Afr Med J. 1987;72:781-783.
32. WHOTechnical Report Series. Rheumatic fever and rheumatic heart disease: report of a who expert panel, Geneva 29 October-1 November 2001. Geneva: WHO, 2004.
33. Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A. Improving chronic illness care: translating evidence into action. Health Affairs (Project Hope). 2001;20:64-78.
34. Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, Camm AJ,Weitz JI, Lewis BS, Parkhomenko A, Yamashita T, Antman EM. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: A meta-analysis of randomised trials. The Lancet 2014;383:955-962.
35. Ellis DJ,Usman MH, Milner PG, Canafax DM, Ezekowitz MD. The first evaluation of a novel vitamin k antagonist, tecarfarin (ati-5923), in patients with atrial fibrillation. Circulation 2009;120:1029-1035.
36. Okuyama Y, Matsuo M, Matsuo H, Sakaguchi Y, Takai H, Horiguchi Y, Ryomoto T, Adachi S, Amano T, Togawa M, Masuda M, Minamiguchi H, Nanto S, Komuro I, Sakata Y. Introduction of point-of-care testing in Japanese outpatient clinics is associated with improvement in time in therapeutic range in anticoagulant-treated patients. Circ J 2014;78:1342-1348.